The role that US federal advisory committees played in the government’s COVID-19 response came under scrutiny at the House Energy and Commerce Committee hearing on 8 February.
Rep. Anna Eshoo, D-Calif., raised concerns that the Food and Drug Administration’s Vaccines and Related Biologics Advisory Committee and the Centers for Disease Control and Prevention’s Advisory Committee on Immunization...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?